Key considerations for discovery in AI-focused intellectual property (IP) litigation, including an examination of a ...

Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

A new study in PLOS Biology shows that deep N2 sleep, rather than light N1 sleep, dramatically boosts the likelihood of “aha” ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an analysis of RHHBY stock now.

Data-intelligence driven methods for durability, damage diagnosis and performance prediction of concrete structures ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - June 23, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the appointment of Andrew Smith as Chief ...

Our systematic review and meta-analysis found a significant association between long-term exposure to fine particulate matter (PM 2.5) and increased dementia risk; stronger evidence links PM 2.5 ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Investigational review board ... submit an interim data analysis to the FDA and to request a Type C meeting and the timing thereof, the Company's aim to fast fast-track the clinical development ...

In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects ...